Summit Therapeutics Inc. Common Stock

Go to Summit Therapeutics Inc. Common Stock Website

$27.30

0.93 (3.53%)
Live
Previous Close

$27.07

Day Range

$25.4107 - $27.44

Previous Day Range

$26.1 - $27.5

Market Cap

$20.1 billion USD

Day Vol.

1.9 million

Previous Day Vol.

2.0 million

Currency

USD

Primary Exchange

Nasdaq

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazo...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

The article explores two promising biotech companies, Viking Therapeutics and Recursion Pharmaceuticals, highlighting their innovative approaches in weight loss treatments and AI-driven drug development, respectively.

Related tickers: VKTX, RXRX, SMMT, ABVX.

Read Full Article

Three pharmaceutical companies - Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals - are poised for potential stock movements based on upcoming clinical trial results in areas like obesity, cancer treatment, and type 1 diabetes.

Related tickers: LLY, SMMT, VRTX.

Read Full Article
Trending Tickers

Please sign in to view